Novo Nordisk Cuts US Sales Team: Cost-Cutting?

Markets & Money Today | 2 Min News | The Daily News Now! - A podcast by The Daily News Now! - Fridays

Try Bookbeat 60! days for free, click here

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

 Sponsored

Categories:

Business

Novo Nordisk slashes its U.S. obesity and diabetes education team in a major restructuring, signaling a cost-cutting strategy to rival Eli Lilly and recover from a $400 billion market cap loss. Find out how this move, impacting hundreds of employees, reflects a shift in Novo's approach to the competitive weight loss drug market. Hosted on Acast. See acast.com/privacy for more information.

Visit the podcast's native language site